NFKB1 and aneurysm: Studies have also confirmed that the use of mitochondrial aldehyde dehydrogenase 2 (ALDH2) activators can reduce Ang II-induced ROS production, NF-κB activation, and apoptosis in human aortic smooth muscle cells (HASMCs), thereby alleviating aneurysm formation and limiting aortic dilation [88].